Healthcare provider profile · identity verified

Flos C Brown, MD

Family Practice · NORFOLK, NY · NPI 1821220120

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	459	134
Losartan Potassium	Losartan Potassium	359	93
Omeprazole	Omeprazole	353	94
Rosuvastatin Calcium	Rosuvastatin Calcium	332	90
Lisinopril	Lisinopril	308	84
Levothyroxine Sodium	Levothyroxine Sodium	266	69
Metoprolol Succinate	Metoprolol Succinate	251	69
Amlodipine Besylate	Amlodipine Besylate	242	65
Albuterol Sulfate Hfa	Albuterol Sulfate	175	46
Pantoprazole Sodium	Pantoprazole Sodium	173	46
Simvastatin	Simvastatin	167	45
Furosemide	Furosemide	161	49
Fluticasone Propionate	Fluticasone Propionate	128	38
Sertraline Hcl	Sertraline Hcl	126	34
Gabapentin	Gabapentin	119	38
Ezetimibe	Ezetimibe	116	32
Hydrochlorothiazide	Hydrochlorothiazide	115	32
Metformin Hcl	Metformin Hcl	114	33
Montelukast Sodium	Montelukast Sodium	109	26
Metoprolol Tartrate	Metoprolol Tartrate	87	27
Baclofen	Baclofen	70	29
Ozempic	Semaglutide	69	12
Allopurinol	Allopurinol	68	19
Fenofibrate	Fenofibrate Nanocrystallized	66	17
Metformin Hcl Er	Metformin Hcl	66	17
Trazodone Hcl	Trazodone Hcl	65	25
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	64	11
Pravastatin Sodium	Pravastatin Sodium	58	19
Eliquis	Apixaban	53	16
Triamcinolone Acetonide	Triamcinolone Acetonide	53	20
Januvia	Sitagliptin Phosphate	51	14
Celecoxib	Celecoxib	48	15
Famotidine	Famotidine	47	13
Bupropion Xl	Bupropion Hcl	46	12
Zolpidem Tartrate	Zolpidem Tartrate	46	suppressed
Chlorthalidone	Chlorthalidone	44	13
Lorazepam	Lorazepam	44	12
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	43	15
Venlafaxine Hcl Er	Venlafaxine Hcl	43	suppressed
Carvedilol	Carvedilol	39	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	39	15
Potassium Chloride	Potassium Chloride	39	13
Tamsulosin Hcl	Tamsulosin Hcl	39	13
Tramadol Hcl	Tramadol Hcl	39	suppressed
Ventolin Hfa	Albuterol Sulfate	39	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	38	11
Fenofibrate	Fenofibrate	37	13
Ropinirole Hcl	Ropinirole Hcl	37	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	36	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	35	12
Esomeprazole Magnesium	Esomeprazole Magnesium	34	suppressed
Glimepiride	Glimepiride	34	suppressed
Nystatin	Nystatin	34	16
Duloxetine Hcl	Duloxetine Hcl	33	suppressed
Jardiance	Empagliflozin	33	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	33	suppressed
Clonazepam	Clonazepam	32	suppressed
Prednisone	Prednisone	31	25
Ibuprofen	Ibuprofen	30	suppressed
Paroxetine Hcl	Paroxetine Hcl	30	suppressed
Warfarin Sodium	Warfarin Sodium	30	suppressed
Mounjaro	Tirzepatide	29	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	28	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	28	11
Citalopram Hbr	Citalopram Hydrobromide	26	suppressed
Meloxicam	Meloxicam	26	suppressed
Valsartan	Valsartan	25	suppressed
Xarelto	Rivaroxaban	25	suppressed
Atenolol	Atenolol	24	suppressed
Oxycodone Hcl	Oxycodone Hcl	24	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	24	suppressed
Pregabalin	Pregabalin	24	suppressed
Clopidogrel	Clopidogrel Bisulfate	23	suppressed
Methylprednisolone	Methylprednisolone	23	19
Synthroid	Levothyroxine Sodium	23	suppressed
Spironolactone	Spironolactone	21	suppressed
Wegovy	Semaglutide	21	suppressed
Azelastine Hcl	Azelastine Hcl	20	suppressed
Glipizide Er	Glipizide	20	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	20	suppressed
Alprazolam	Alprazolam	19	suppressed
Buspirone Hcl	Buspirone Hcl	19	suppressed
Diltiazem Hcl	Diltiazem Hcl	19	suppressed
Finasteride	Finasteride	18	suppressed
Nystop	Nystatin	18	suppressed
Ramipril	Ramipril	18	suppressed
Enalapril Maleate	Enalapril Maleate	17	suppressed
Fluconazole	Fluconazole	17	11
Lovastatin	Lovastatin	17	suppressed
Ketoconazole	Ketoconazole	16	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	16	suppressed
Nitroglycerin	Nitroglycerin	16	suppressed
Tizanidine Hcl	Tizanidine Hcl	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Breyna	Budesonide/Formoterol Fumarate	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Lansoprazole	Lansoprazole	15	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	15	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	12
Gemfibrozil	Gemfibrozil	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Azithromycin	Azithromycin	12	12
Carisoprodol	Carisoprodol	12	suppressed
Fentanyl	Fentanyl	12	suppressed
Glipizide	Glipizide	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	12	suppressed
Epinephrine	Epinephrine	11	suppressed
Naproxen	Naproxen	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Solifenacin Succinate	Solifenacin Succinate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error